CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer
Titel:
CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer
Auteur:
Thalji, Sam Z. Kamgar, Mandana George, Ben Aldakkak, Mohammed Christians, Kathleen K. Clarke, Callisia N. Erickson, Beth A. Hall, William A. Tolat, Parag P. Smith, Zachary L. Evans, Douglas B. Tsai, Susan